Bio-Techne Corporation operates in the biotechnology sector, heavily influencing markets related to life science reagents and diagnostics. With a broad product portfolio and significant global presence, the company's recent performance suggests strong resilience in a competitive market. However, potential investors should keep an eye on industry trends and regulatory changes affecting the biotechnology field.
The fundamental ratings reflect Bio-Techne Corporation's performance across several financial metrics. The overall score indicates a respectable standing, with notable strengths and some areas for improvement.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 3 | |
| Return on Assets | 4 | |
| Debt to Equity | 3 | |
| Price to Earnings | 1 | |
| Price to Book | 2 |
The historical data provides insight into the recent changes in financial metrics, showcasing stability over the set period.
| Date | Overall Score | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-07-07 | 3 | 3 | 3 | 4 | 3 | 1 | 2 |
| Past Period | 0 | 3 | 3 | 4 | 3 | 1 | 2 |
Analyst estimates suggest a bullish outlook with considerable potential for upside movement in Bio-Techne's stock price.
| High | Low | Median | Consensus |
|---|---|---|---|
| $79 | $50 | $73 | $66.44 |
The prevailing sentiment among analysts is positive, with a majority recommending purchasing the stock, suggesting potential growth.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 14 | |
| Hold | 12 | |
| Sell | 0 | |
| Strong Sell | 0 |
Bio-Techne Corporation exhibits solid performance with specific strengths in return on assets, positioning it well in its sector. While its price-to-earnings ratio suggests potential overvaluation, analyst confidence strengthens its outlook. Investors should monitor external factors such as macroeconomic conditions and sector-specific trends. Overall, the stock presents promising growth opportunities, albeit with inherent risks.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.